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Background
Traumatic Brain Injury (TBI) is defined as 
damage to the brain, resulting from an 
external mechanical force.1 TBI is currently 
the leading cause of death and disability in 
children and young adults, with 1.7 million 
reported cases annually in the United States 
alone.2 The initial trauma is followed by 
secondary corrosive damage to the brain.  
There are currently no treatments to protect 
the brain from this deterioration. The aim for 
this project was to study the effects of 
nanoparticle (NP) treatments on reducing 
this secondary damage using a mouse model 
of TBI.  
Nanoparticle Therapy
Secondary damage is caused by an increase 
in oxidative stress, which forces a 
biochemical imbalance in the brain.  The 
spread of reactive oxygen species (ROS) is 
one of the main components for the long-
term development in TBI.  We used the 
NPs of Yoo et al. 2017, shown in Figure 1, 
in efforts to bind and inactivate ROS, 
reducing the spread of damage.3
Discussion
Based on the data collected from 
these SOD assay experiments, 
evidence showed that NPs 
reduced the spread of oxidative 
stress to the contralateral brain 
suggested by the reduction of 
SOD activity in comparison to 
the injured animals that did not 
receive NPs. Additional studies 
are needed in order to confirm 
the benefits of NPs in reducing 
the spread of ROS, however, this 
project offers promise for the 
promotion of future research.  
Superoxide Dismutase Activity Assay
Superoxide Dismutase (SOD) is an antioxidant enzyme involved in the body’s 
oxidative equilibrium system, which converts ROS into oxygen and hydrogen 
peroxide, as shown in Figure 2.4 Xanthine Oxidase (XO) is an enzyme that 
catalyzes the reaction of hypoxanthine into uric acid and ROS.5 Hypoxanthine 
is a purine derivative catabolized from nucleic acids or ATP.  In this assay, 
Tetrazolium Salt WST-1 is reduced into a water soluble dye upon the reaction 
with ROS. SOD will reduce levels of ROS, which are generated by XO, by 
converting them into oxygen and hydrogen peroxide.  The higher the levels of 
SOD activity, the less dye will be produced. In order to counter oxidative stress, 
brain tissue will increase the expression of SOD.  Our hypothesis states that NP 
treatments will reduce oxidative stress in the brain, reducing SOD expression.
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Controlled Cortical Impact
Controlled Cortical Impact (CCI) is a 
commonly utilized method for modeling a 
TBI. The impactor is placed over the left 
frontoparietal cortex of the mouse’s brain. 
Impact parameters include 4 m/s velocity to 
a depth of 2.5 mm with a 80 ms dwell time 
followed by NP tail vein injections.
Figure 2: 
Diagram illustrating the 
conversion of ROS into Oxygen 
and Hydrogen Peroxide by the 
enzyme, SOD.
Figure 1:
Thioether core NPs 
utilized in these 
experiments.
Analysis was conducted using the data 
collected from the SOD assay experiments, 
after 24 hours following CCI experiments.  
From the results provided in Figure 3, brain 
samples from the left and right sides of the 
brain following CCI experiments contained 
higher levels of SOD activity than the 
control.  Additionally, brain samples from 
the right side of the brain, which did not 
receive NP treatment had higher levels of 
SOD Activity, than samples that received  
treatment.  
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Figure 3:
SOD Activity normalized to protein concentration of brain samples, 
after 24 hr. following CCI experiments.  Samples include left  and 
right (L/R) sides of the brain for mice with (NP) and without (CCI) 
NP treatment, in addition to a sample control (C) that did not 
receive damage.
